B244
B244 is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
6
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
Clinical Trials (7)
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7